U.S. Pruritus Treatment Market (Pruritus Type: Systemic Diseases, Skin Diseases, Neurologic Diseases, Nocturnal Pruritus, Pruritus Ani, and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

U.S. Pruritus Treatment Market – Scope of Report


TMR’s report on the U.S. Pruritus Treatment Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the U.S. Pruritus Treatment Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the U.S. Pruritus Treatment Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Plasmonic Materials market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Plasmonic Materials market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Plasonic Materials market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Plasmonic Materials market.

The report delves into the competitive landscape of the global Plasmonic Materials market. Key players operating in the U.S. Pruritus Treatment Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the U.S. Pruritus Treatment Market profiled in this report.

Key Questions Answered in U.S. Pruritus Treatment Market Report

  • What is the sales/revenue generated by Plasmonic Materials across all regions during the forecast period?
  • What are the opportunities in the global Plasmonic Materials market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

U.S. Pruritus Treatment Market – Research Objectives and Research Approach


The comprehensive report on the U.S. Pruritus Treatment Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the U.S. Pruritus Treatment Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Plasmonic Materials market.

U.S. Pruritus Treatment Market – Scope of Report


TMR’s report on the U.S. Pruritus Treatment Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the U.S. Pruritus Treatment Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the U.S. Pruritus Treatment Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Plasmonic Materials market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Plasmonic Materials market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Plasonic Materials market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Plasmonic Materials market.

The report delves into the competitive landscape of the global Plasmonic Materials market. Key players operating in the U.S. Pruritus Treatment Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the U.S. Pruritus Treatment Market profiled in this report.

Key Questions Answered in U.S. Pruritus Treatment Market Report

  • What is the sales/revenue generated by Plasmonic Materials across all regions during the forecast period?
  • What are the opportunities in the global Plasmonic Materials market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

U.S. Pruritus Treatment Market – Research Objectives and Research Approach


The comprehensive report on the U.S. Pruritus Treatment Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the U.S. Pruritus Treatment Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Plasmonic Materials market.


1. Preface
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. Pruritus Treatment Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. U.S. Pruritus Treatment Market Analysis and Forecast, 2017-2031
4.3.1. Market Revenue Projections (US$ Mn)
4.3.2. Market Volume Projections (Thousand Units)
5. Key Insights
5.1. Porter’s Five Forces Analysis
5.2. Disease Prevalence & Incidence Rate
5.3. Pricing Analysis
5.4. Overview and Application of OTC Products in Treatment of Pruritus
5.5. COVID-19 Impact Analysis
6. U.S. Pruritus Treatment Market Analysis and Forecast, by Pruritus Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Pruritus Type, 2017-2031
6.3.1. Systemic Diseases
6.3.1.1. Cancer
6.3.1.2. Liver Disease
6.3.1.3. Kidney Disease
6.3.1.4. Others
6.3.2. Skin Diseases
6.3.2.1. Eczema
6.3.2.2. Atopic Dermatitis
6.3.2.3. Others
6.3.3. Neurologic Diseases
6.3.3.1. Shingles
6.3.3.2. Multiple Sclerosis
6.3.3.3. Others
6.3.4. Nocturnal Pruritus
6.3.5. Pruritus Ani
6.3.6. Others
6.4. Market Attractiveness Analysis, by Pruritus Type
7. U.S. Pruritus Treatment Market Analysis and Forecast, by Drug Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value & Volume Forecast, by Drug Type, 2017-2031
7.3.1. Antihistamines
7.3.2. Calcineurin Inhibitors
7.3.3. Selective Serotonin Reuptake Inhibitors
7.3.4. Corticosteroids
7.3.5. Calamine
7.3.6. Neuroleptics
7.3.7. Others
7.4. Market Attractiveness Analysis, by Drug Type
8. U.S. Pruritus Treatment Market Analysis and Forecast, by Sales Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value & Volume Forecast, by Sales Type, 2017 - 2031
8.3.1. Rx Sales
8.3.2. OTC Sales
8.4. Market Attractiveness Analysis, by Sales Type
9. U.S. Pruritus Treatment Market Analysis and Forecast, by Dosage Form
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value & Volume Forecast, by Dosage Form, 2017-2031
9.3.1. Topical
9.3.2. Oral
9.4. Market Attractiveness Analysis, by Dosages Form
10. U.S. Pruritus Treatment Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Distribution Channel, 2017-2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Competition Landscape
11.1. Market Player - Competition Matrix (by tier and size of companies)
11.2. Market Share Analysis, by Company, 2021
11.3. Company Profiles
11.3.1. AbbVie, Inc. (Allergan plc)
11.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.1.2. Test Type Portfolio
11.3.1.3. Financial Overview
11.3.1.4. SWOT Analysis
11.3.1.5. Strategic Overview
11.3.2. Albireo Pharma, Inc.
11.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.2.2. Test Type Portfolio
11.3.2.3. Financial Overview
11.3.2.4. SWOT Analysis
11.3.2.5. Strategic Overview
11.3.3. Astellas Pharma, Inc.
11.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.3.2. Test Type Portfolio
11.3.3.3. Financial Overview
11.3.3.4. SWOT Analysis
11.3.3.5. Strategic Overview
11.3.4. Cipla Limited
11.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.4.2. Test Type Portfolio
11.3.4.3. Financial Overview
11.3.4.4. SWOT Analysis
11.3.4.5. Strategic Overview
11.3.5. Eli Lilly and Company
11.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.5.2. Test Type Portfolio
11.3.5.3. Financial Overview
11.3.5.4. SWOT Analysis
11.3.5.5. Strategic Overview
11.3.6. GSK plc
11.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.6.2. Test Type Portfolio
11.3.6.3. Financial Overview
11.3.6.4. SWOT Analysis
11.3.6.5. Strategic Overview
11.3.7. Merck & Co., Inc.
11.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.7.2. Test Type Portfolio
11.3.7.3. Financial Overview
11.3.7.4. SWOT Analysis
11.3.7.5. Strategic Overview
11.3.8. Pfizer, Inc.
11.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.8.2. Test Type Portfolio
11.3.8.3. Financial Overview
11.3.8.4. SWOT Analysis
11.3.8.5. Strategic Overview
11.3.9. Teva Pharmaceutical Industries Ltd.
11.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.9.2. Test Type Portfolio
11.3.9.3. Financial Overview
11.3.9.4. SWOT Analysis
11.3.9.5. Strategic Overview
11.3.10. Viatris Inc. (Mylan N.V.)
11.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
11.3.10.2. Test Type Portfolio
11.3.10.3. Financial Overview
11.3.10.4. SWOT Analysis
11.3.10.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings